Funding Rounds
Biofidelity

Biofidelity Series A (2020, $12M)

Biofidelity

Genomic technology developer to detect biomarkers for non-small cell lung cancer (NSCLC).

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $12.00M

Raised Date: 2020-01-01

Investors